Skip to main content
Fig. 3 | Health and Quality of Life Outcomes

Fig. 3

From: Effect of low-normal and high-normal IGF-1 levels on memory and wellbeing during growth hormone replacement therapy: a randomized clinical trial in adult growth hormone deficiency

Fig. 3

Mean (± SEM) and individual POMS Fatigue and Vigor scores of females and males in the low dose (dashed line) and high dose (solid line) groups at baseline and at week 24 (higher scores meaning more fatigue and more vigor). * p < 0.05 for mean score at week 24 compared to baseline per group

Back to article page